reports that pursuant to its Stock Option Plan, it has granted stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,400,000 common shares in the capital of the Company at an exercise price of $0.08 per share, which expire on March 27, 2026. Following this stock option grant, the Company has a
[...]